EntroVac Adverse Reactions

According to Council for International Organizations of Medical Sciences (CIOMS), the incidence of adverse reactions can be described as follows: very common (≥10%), common (1%-10%, including 1%), uncommon (0.1%-1%, including 0.1%), rare (0.01%-0.1%, including 0.01%), very rare (<0.01%), which are described as follows: Very common: Systemic reaction: Pyrexia.
Common: Local reaction: Pain, erythema, swell, induration.
Systemic reaction: Decreased appetite, irritability postvaccinal, diarrhea, nausea, vomiting, fatigue, hypersensitivity.
Uncommon: Local reaction: Pruritus.
The following adverse reactions were observed in the process of using other inactivated virus vaccines: 1) regional lymphadenopathy at the injection site; 2) hypersensitivity caused by each composition contained in the vaccine: urticaria, allergic eruption, anaphylactoid purpura and allergic shock; 3) convulsions (accompanied by fever or not) and so on. Although this vaccine has not generated previously mentioned adverse reactions in the clinical trials before it is in post-marketing, attentions should be continually paid on its subsequent use.